Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 1
1966 1
1971 2
1973 2
1974 1
1975 1
1976 2
1977 2
1978 3
1979 2
1980 2
1981 3
1982 6
1983 3
1984 1
1985 2
1987 1
1988 4
1990 1
1991 4
1992 1
1993 2
1995 3
1996 7
1997 3
1998 3
1999 2
2000 5
2001 9
2002 3
2003 3
2004 12
2005 12
2006 10
2007 19
2008 20
2009 22
2010 24
2011 28
2012 34
2013 39
2014 31
2015 53
2016 48
2017 39
2018 46
2019 49
2020 57
2021 49
2022 50
2023 74
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

781 results

Results by year

Filters applied: . Clear all
Page 1
Aducanumab: First Approval.
Dhillon S. Dhillon S. Drugs. 2021 Aug;81(12):1437-1443. doi: 10.1007/s40265-021-01569-z. Drugs. 2021. PMID: 34324167 Review.
Zavegepant: First Approval.
Dhillon S. Dhillon S. Drugs. 2023 Jun;83(9):825-831. doi: 10.1007/s40265-023-01885-6. Drugs. 2023. PMID: 37227596 Free PMC article. Review.
Telitacicept: First Approval.
Dhillon S. Dhillon S. Drugs. 2021 Sep;81(14):1671-1675. doi: 10.1007/s40265-021-01591-1. Drugs. 2021. PMID: 34463932 Review.
Beremagene Geperpavec: First Approval.
Dhillon S. Dhillon S. Drugs. 2023 Aug;83(12):1131-1135. doi: 10.1007/s40265-023-01921-5. Drugs. 2023. PMID: 37432558 Review.
Therapeutic Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy.
Wassink G, Davidson JO, Dhillon SK, Zhou K, Bennet L, Thoresen M, Gunn AJ. Wassink G, et al. Among authors: dhillon sk. Curr Neurol Neurosci Rep. 2019 Jan 14;19(2):2. doi: 10.1007/s11910-019-0916-0. Curr Neurol Neurosci Rep. 2019. PMID: 30637551 Review.
Elranatamab: First Approval.
Dhillon S. Dhillon S. Drugs. 2023 Nov;83(17):1621-1627. doi: 10.1007/s40265-023-01954-w. Drugs. 2023. PMID: 37924427 Review.
Fidanacogene Elaparvovec: First Approval.
Dhillon S. Dhillon S. Drugs. 2024 Apr;84(4):479-486. doi: 10.1007/s40265-024-02017-4. Epub 2024 Mar 12. Drugs. 2024. PMID: 38472707 Review.
Adagrasib: First Approval.
Dhillon S. Dhillon S. Drugs. 2023 Feb;83(3):275-285. doi: 10.1007/s40265-023-01839-y. Drugs. 2023. PMID: 36763320 Review.
Ketamine: a versatile tool for anesthesia and analgesia.
Barrett W, Buxhoeveden M, Dhillon S. Barrett W, et al. Among authors: dhillon s. Curr Opin Anaesthesiol. 2020 Oct;33(5):633-638. doi: 10.1097/ACO.0000000000000916. Curr Opin Anaesthesiol. 2020. PMID: 32826629 Review.
Sunvozertinib: First Approval.
Dhillon S. Dhillon S. Drugs. 2023 Nov;83(17):1629-1634. doi: 10.1007/s40265-023-01959-5. Drugs. 2023. PMID: 37962831 Review.
781 results